191 related articles for article (PubMed ID: 19060116)
1. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
Xu J; Carretero OA; Shesely EG; Rhaleb NE; Yang JJ; Bader M; Yang XP
Exp Physiol; 2009 Mar; 94(3):322-9. PubMed ID: 19060116
[TBL] [Abstract][Full Text] [Related]
2. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
[TBL] [Abstract][Full Text] [Related]
3. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
4. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
5. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
Xu J; Carretero OA; Liu YH; Shesely EG; Yang F; Kapke A; Yang XP
Hypertension; 2002 Sep; 40(3):244-50. PubMed ID: 12215461
[TBL] [Abstract][Full Text] [Related]
6. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
8. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K
Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458
[TBL] [Abstract][Full Text] [Related]
9. Protective role of AT(2) and B(1) receptors in kinin B(2)-receptor-knockout mice with myocardial infarction.
Xu J; Carretero OA; Zhu L; Shesely EG; Rhaleb NE; Dai X; Wang L; Yang JJ; Yang XP
Clin Sci (Lond); 2013 Jan; 124(2):87-96. PubMed ID: 22849668
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
11. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats.
Zhang RY; Wang LF; Zhang L; Meng XN; Li SJ; Wang WR
Chin Med J (Engl); 2006 Apr; 119(8):649-55. PubMed ID: 16635409
[TBL] [Abstract][Full Text] [Related]
14. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.
Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of valsartan against progression of left ventricular dysfunction after myocardial infarction: T-VENTURE study.
Suzuki H; Geshi E; Nanjyo S; Nakano H; Yamazaki J; Sato N; Tanaka K; Takano T; Yagi H; Shibata T; Mochizuki S; Katagiri T
Circ J; 2009 May; 73(5):918-24. PubMed ID: 19346662
[TBL] [Abstract][Full Text] [Related]
16. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
[TBL] [Abstract][Full Text] [Related]
17. Valsartan in the treatment of heart attack survivors.
Jugdutt BI
Vasc Health Risk Manag; 2006; 2(2):125-38. PubMed ID: 17319456
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
19. Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction.
Bissessor N; White H
Vasc Health Risk Manag; 2007; 3(4):425-30. PubMed ID: 17969373
[TBL] [Abstract][Full Text] [Related]
20. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
Grandi AM; Solbiati F; Laurita E; Maresca AM; Nicolini E; Marchesi C; Gianni M; Guasti L; Venco A
Am J Hypertens; 2008 Feb; 21(2):231-7. PubMed ID: 18174880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
